Pharvaris N.V.
Pharvaris N.V. (PHVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHVS · as of Jun 8, 2026
Key Statistics
Explore Pharvaris N.V. Data
phvs stock data · financialsCompetitors & Peers
phvs competitorsPHVS
ARDX
BCRX
IMNM
MAZE
NTLAAbout Pharvaris N.V.
Pharvaris N.V. a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2…
what is pharvaris n.v. · phvs stock overview · pharvaris n.v. company profile · who is pharvaris n.v. ceo · phvs NASDAQ · pharvaris n.v. headquarters · pharvaris n.v. business segments
About Stock Overview & Key Data
Pharvaris N.V. (PHVS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, PHVS stock price is $31.65, with a market capitalization of $2.2B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Pharvaris N.V. (PHVS) stock price is $31.65. The stock is traded on NASDAQ under the ticker symbol PHVS. The 52-week range is $15.91 – $33.33.